Rare diseases
Investigational molecules
Locations
Struempellstrasse 42, Probstheida, 04289 Leipzig, Germany
Onkopraxis Probstheida in Leipzig, Germany specialises in clinical trials of conditions such as Chronic lymphocytic leukaemia, Colon cancer stage II, Oesophageal adenocarcinoma, Rectal cancer, and other specialisations. This site conducts important research.
The clinic concentrates on advancing care for solid tumors, particularly colorectal cancer and Hodgkin lymphoma, by testing novel adjuvant therapy approaches and less toxic treatment options.
With three active studies and two investigators, Onkopraxis Probstheida seeks to boost disease‑free survival while minimizing treatment‑related morbidity for patients with stage II colon and rectal cancers and for those battling advanced Hodgkin lymphoma.
Clinical trials registered at this site – none is enrolling right now.
GermanyStudy Comparing FOLFOX Before Surgery to Risk-Adapted Chemotherapy After Surgery for Patients with Locally Advanced Rectal Cancer and Low Risk of Local Failure
GermanyStudy on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal
GermanyStudy Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients
GermanyStudy of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
